AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 1-25/60
SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP
Authors: GULICK RM MELLORS JW HAVLIR D ERON JJ GONZALEZ C MCMAHON D JONAS L MEIBOHM A HOLDER D SCHLEIF WA CONDRA JH EMINI EA ISAACS R CHODAKEWITZ JA RICHMAN DD
Citation: Rm. Gulick et al., SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 35-41
NEW DEVELOPMENTS IN THE BIOLOGY AND TREATMENT OF HIV
Authors: BUSHMAN F LANDAU NR EMINI EA
Citation: F. Bushman et al., NEW DEVELOPMENTS IN THE BIOLOGY AND TREATMENT OF HIV, Proceedings of the National Academy of Sciences of the United Statesof America, 95(19), 1998, pp. 11041-11042
FACTORS INFLUENCING THE EMERGENCE OF RESISTANCE TO INDINAVIR - ROLE OF VIROLOGICAL, IMMUNOLOGICAL, AND PHARMACOLOGICAL VARIABLES
Authors: DRUSANO GL BILELLO JA STEIN DS NESSLY M MEIBOHM A EMINI EA DEUTSCH P CONDRA J CHODAKEWITZ J HOLDER DJ
Citation: Gl. Drusano et al., FACTORS INFLUENCING THE EMERGENCE OF RESISTANCE TO INDINAVIR - ROLE OF VIROLOGICAL, IMMUNOLOGICAL, AND PHARMACOLOGICAL VARIABLES, The Journal of infectious diseases, 178(2), 1998, pp. 360-367
CRIXIVAN(R) - A POTENT INHIBITOR OF HIV-1 PROTEASE IN-VIVO
Authors: HUFF JR VACCA JP DORSEY BD EMINI EA CONDRA JH SCHLEIF WA MASSARI FE DEUTSCH PJ CHODAKEWITZ J KUO LC CHEN Z
Citation: Jr. Huff et al., CRIXIVAN(R) - A POTENT INHIBITOR OF HIV-1 PROTEASE IN-VIVO, The FASEB journal, 11(9), 1997, pp. 23-23
RECOMBINANT HUMAN MONOCLONAL-ANTIBODY IGG1B12 NEUTRALIZES DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMARY ISOLATES
Authors: KESSLER JA MCKENNA PM EMINI EA CHAN CP PATEL MD GUPTA SK MARK GE BARBAS CF BURTON DR CONLEY AJ
Citation: Ja. Kessler et al., RECOMBINANT HUMAN MONOCLONAL-ANTIBODY IGG1B12 NEUTRALIZES DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMARY ISOLATES, AIDS research and human retroviruses, 13(7), 1997, pp. 575-582
TREATMENT WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE IN ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND PRIOR ANTIRETROVIRAL THERAPY
Authors: GULICK RM MELLORS JW HAVLIR D ERON JJ GONZALEZ C MCMAHON D RICHMAN DD VALENTINE FT JONAS L MEIBOHM A EMINI EA CHODAKEWITZ JA
Citation: Rm. Gulick et al., TREATMENT WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE IN ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND PRIOR ANTIRETROVIRAL THERAPY, The New England journal of medicine, 337(11), 1997, pp. 734-739
GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR
Authors: CONDRA JH HOLDER DJ SCHLEIF WA BLAHY OM DANOVICH RM GABRYELSKI LJ GRAHAM DJ LAIRD D QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M YANG T CHODAKEWITZ JA DEUTSCH PJ LEAVITT RY MASSARI FE MELLORS JW SQUIRES KE STEIGBIGEL RT TEPPLER H EMINI EA
Citation: Jh. Condra et al., GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Journal of virology, 70(12), 1996, pp. 8270-8276
THE CONSEQUENCE OF PASSIVE ADMINISTRATION OF AN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING MONOCLONAL-ANTIBODY BEFORE CHALLENGE OF CHIMPANZEES WITH A PRIMARY VIRUS ISOLATE
Authors: CONLEY AJ KESSLER JA BOOTS LJ MCKENNA PM SCHLEIF WA EMINI EA MARK GE KATINGER H COBB EK LUNCEFORD SM ROUSE SR MURTHY KK
Citation: Aj. Conley et al., THE CONSEQUENCE OF PASSIVE ADMINISTRATION OF AN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING MONOCLONAL-ANTIBODY BEFORE CHALLENGE OF CHIMPANZEES WITH A PRIMARY VIRUS ISOLATE, Journal of virology, 70(10), 1996, pp. 6751-6758
CORRELATION BETWEEN GENOTYPIC EVIDENCE OF HIV-1 RESISTANCE TO THE PROTEASE INHIBITOR MK-639 AND LOSS OF ANTIRETROVIRAL EFFECT IN TREATED PATIENTS
Authors: MELLORS JW MCMAHON DK CHODAKEWITZ JA SCHLEIF WA EMINI EA CONDRA JH
Citation: Jw. Mellors et al., CORRELATION BETWEEN GENOTYPIC EVIDENCE OF HIV-1 RESISTANCE TO THE PROTEASE INHIBITOR MK-639 AND LOSS OF ANTIRETROVIRAL EFFECT IN TREATED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 71-71
DYNAMICS OF ACQUIRED HIV-1 CLINICAL RESISTANCE TO THE PROTEASE INHIBITOR MK-639
Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T ZHANG J CHODAKEWITZ JA DEUTSCH PJ EMINI EA
Citation: Jh. Condra et al., DYNAMICS OF ACQUIRED HIV-1 CLINICAL RESISTANCE TO THE PROTEASE INHIBITOR MK-639, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 72-72
EVIDENCE FOR THE EXISTENCE OF LONG-LIVED GENETIC RESERVOIRS OF HIV-1 IN INFECTED PATIENTS
Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T ZHANG J DEUTSCH PJ SQUIRES KE EMINI EA
Citation: Jh. Condra et al., EVIDENCE FOR THE EXISTENCE OF LONG-LIVED GENETIC RESERVOIRS OF HIV-1 IN INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 82-82
ASSESSMENT OF ANTIRETROVIRAL THERAPY BY PLASMA VIRAL LOAD TESTING - STANDARD AND ICD HIV-1 P24 ANTIGEN AND VIRAL-RNA (QC-PCR) ASSAYS COMPARED
Authors: KAPPES JC SAAG MS SHAW GM HAHN BH CHOPRA P CHEN QD EMINI EA MCFARLAND R YANG LC PIATAK M LIFSON JD
Citation: Jc. Kappes et al., ASSESSMENT OF ANTIRETROVIRAL THERAPY BY PLASMA VIRAL LOAD TESTING - STANDARD AND ICD HIV-1 P24 ANTIGEN AND VIRAL-RNA (QC-PCR) ASSAYS COMPARED, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 139-149
SYNTHESIS AND EVALUATION OF PYRIDYL ANALOGS OF L-735,524 - POTENT HIV-1 PROTEASE INHIBITORS (VOL 4, PG 2769, 1994)
Authors: DORSEY BD MCDANIEL SL LEVIN RB VACCA JP DARKE PL ZUGAY JA EMINI EA SCHLEIF WA LIN JH CHEN IW HOLLOWAY MK ANDERSON PS HUFF JR
Citation: Bd. Dorsey et al., SYNTHESIS AND EVALUATION OF PYRIDYL ANALOGS OF L-735,524 - POTENT HIV-1 PROTEASE INHIBITORS (VOL 4, PG 2769, 1994), Bioorganic & medicinal chemistry letters, 5(7), 1995, pp. 773-773
CYCLOALKYLPIPERAZINES AS HIV-1 PROTEASE INHIBITORS - ENHANCED ORAL ABSORPTION
Authors: KIM BM EVANS BE GILBERT KF HANIFIN CM VACCA JP MICHELSON SR DARKE PL ZUGAY JA EMINI EA SCHLEIF W LIN JH CHEN IW VASTAG K ANDERSON PS HUFF JR
Citation: Bm. Kim et al., CYCLOALKYLPIPERAZINES AS HIV-1 PROTEASE INHIBITORS - ENHANCED ORAL ABSORPTION, Bioorganic & medicinal chemistry letters, 5(22), 1995, pp. 2707-2712
THIOPHENE DERIVATIVES AS EXTREMELY HIGH-AFFINITY P-3' LIGANDS FOR THEHYDROXYETHYLPIPERAZINE CLASS OF HIV-1 PROTEASE INHIBITORS
Authors: KIM BM GUARE JP VACCA JP MICHELSON SR DARKE PL ZUGAY JA EMINI EA SCHLEIF W LIN JH CHEN IW VASTAG K ANDERSON PS HUFF JR
Citation: Bm. Kim et al., THIOPHENE DERIVATIVES AS EXTREMELY HIGH-AFFINITY P-3' LIGANDS FOR THEHYDROXYETHYLPIPERAZINE CLASS OF HIV-1 PROTEASE INHIBITORS, Bioorganic & medicinal chemistry letters, 5(2), 1995, pp. 185-190
SUBSTITUTED ALKYLPYRIDINES AS P-3' LIGANDS FOR THE HYDROXYETHYLPIPERAZINE CLASS OF HIV-1 PROTEASE INHIBITORS - IMPROVED PHARMACOKINETIC PROFILES
Authors: KIM BM HANIFIN CM ZARTMAN CB VACCA JP MICHELSON SR LIN JH CHEN IW VASTAG K DARKE PL ZUGAY JA EMINI EA SCHLEIF W ANDERSON PS HUFF JR
Citation: Bm. Kim et al., SUBSTITUTED ALKYLPYRIDINES AS P-3' LIGANDS FOR THE HYDROXYETHYLPIPERAZINE CLASS OF HIV-1 PROTEASE INHIBITORS - IMPROVED PHARMACOKINETIC PROFILES, Bioorganic & medicinal chemistry letters, 5(19), 1995, pp. 2239-2244
MOLECULAR MECHANISMS OF ANTIVIRAL RESISTANCE
Authors: KIMBERLIN DW COEN DM BIRON KK COHEN JI LAMB RA MCKINLAY M EMINI EA WHITLEY RJ
Citation: Dw. Kimberlin et al., MOLECULAR MECHANISMS OF ANTIVIRAL RESISTANCE, Antiviral research, 26(4), 1995, pp. 369-401
INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE BY BIS-CATECHOLS
Authors: LAFEMINA RL GRAHAM PL LEGROW K HASTINGS JC WOLFE A YOUNG SD EMINI EA HAZUDA DJ
Citation: Rl. Lafemina et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE BY BIS-CATECHOLS, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 320-324
L-743,726 (DMP-266) - A NOVEL, HIGHLY POTENT NONNUCLEOSIDE INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
Authors: YOUNG SD BRITCHER SF TRAN LO PAYNE LS LUMMA WC LYLE TA HUFF JR ANDERSON PS OLSEN DB CARROLL SS PETTIBONE DJ OBRIEN JA BALL RG BALANI SK LIN JH CHEN IW SCHLEIF WA SARDANA VV LONG WJ BYRNES VW EMINI EA
Citation: Sd. Young et al., L-743,726 (DMP-266) - A NOVEL, HIGHLY POTENT NONNUCLEOSIDE INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2602-2605
IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS
Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T TEPPLER H SQUIRES KE DEUTSCH PJ EMINI EA
Citation: Jh. Condra et al., IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS, Nature, 374(6522), 1995, pp. 569-571
VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: WEI XP GHOSH SK TAYLOR ME JOHNSON VA EMINI EA DEUTSCH P LIFSON JD BONHOEFFER S NOWAK MA HAHN BH SAAG MS SHAW GM
Citation: Xp. Wei et al., VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, Nature, 373(6510), 1995, pp. 117-122
A VACCINE-ELICITED, SINGLE VIRAL EPITOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSE DOES NOT PROTECT AGAINST INTRAVENOUS, CELL-FREE SIMIAN IMMUNODEFICIENCY VIRUS CHALLENGE
Authors: YASUTOMI Y KOENIG S WOODS RM MADSEN J WASSEF NM ALVING CR KLEIN HJ NOLAN TE BOOTS LJ KESSLER JA EMINI EA CONLEY AJ LETVIN NL
Citation: Y. Yasutomi et al., A VACCINE-ELICITED, SINGLE VIRAL EPITOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSE DOES NOT PROTECT AGAINST INTRAVENOUS, CELL-FREE SIMIAN IMMUNODEFICIENCY VIRUS CHALLENGE, Journal of virology, 69(4), 1995, pp. 2279-2284
TURNOVER OF CIRCULATING VIRION RNA AND OF CELL-ASSOCIATED VIRAL-DNA REFLECTS ACTIVE VIRAL REPLICATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS
Authors: LINEBERGER DW KESSLER JA WATERBURY JA BYRNES VW MASSARI F STASZEWSKI S EMINI EA
Citation: Dw. Lineberger et al., TURNOVER OF CIRCULATING VIRION RNA AND OF CELL-ASSOCIATED VIRAL-DNA REFLECTS ACTIVE VIRAL REPLICATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS, Journal of virology, 69(4), 1995, pp. 2637-2639
COMBINATION THERAPY WITH ZIDOVUDINE PREVENTS SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS EXPRESSING HIGH-LEVEL RESISTANCE TO L-697,661, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR
Authors: STASZEWSKI S MASSARI FE KOBER A GOHLER R DURR S ANDERSON KW SCHNEIDER CL WATERBURY JA BAKSHI KK TAYLOR VI HILDEBRAND CS KREISL C HOFFSTEDT B SCHLEIF WA VONBRIESEN H RUBSAMENWAIGMANN H CALANDRA GB RYAN JL STILLE W EMINI EA BYRNES VW
Citation: S. Staszewski et al., COMBINATION THERAPY WITH ZIDOVUDINE PREVENTS SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS EXPRESSING HIGH-LEVEL RESISTANCE TO L-697,661, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, The Journal of infectious diseases, 171(5), 1995, pp. 1159-1165
PYRROLINONE-BASED HIV PROTEASE INHIBITORS - DESIGN, SYNTHESIS, AND ANTIVIRAL ACTIVITY - EVIDENCE FOR IMPROVED TRANSPORT
Authors: SMITH AB HIRSCHMANN R PASTERNAK A GUZMAN MC YOKOYAMA A SPRENGELER PA DARKE PL EMINI EA SCHLEIF WA
Citation: Ab. Smith et al., PYRROLINONE-BASED HIV PROTEASE INHIBITORS - DESIGN, SYNTHESIS, AND ANTIVIRAL ACTIVITY - EVIDENCE FOR IMPROVED TRANSPORT, Journal of the American Chemical Society, 117(45), 1995, pp. 11113-11123
Risultati: 1-25 | 26-50 | 51-60